BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34201561)

  • 1. Exploring New Scaffolds for the Dual Inhibition of HIV-1 RT Polymerase and Ribonuclease Associated Functions.
    Meleddu R; Corona A; Distinto S; Cottiglia F; Deplano S; Sequeira L; Secci D; Onali A; Sanna E; Esposito F; Cirone I; Ortuso F; Alcaro S; Tramontano E; Mátyus P; Maccioni E
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34201561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions.
    Corona A; Onnis V; Deplano A; Bianco G; Demurtas M; Distinto S; Cheng YC; Alcaro S; Esposito F; Tramontano E
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28859311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase.
    Meleddu R; Distinto S; Corona A; Bianco G; Cannas V; Esposito F; Artese A; Alcaro S; Matyus P; Bogdan D; Cottiglia F; Tramontano E; Maccioni E
    Eur J Med Chem; 2015 Mar; 93():452-60. PubMed ID: 25728026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase.
    Meleddu R; Distinto S; Corona A; Tramontano E; Bianco G; Melis C; Cottiglia F; Maccioni E
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):130-136. PubMed ID: 27766892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and molecular docking of pyrazolo [3,4d] thiazole hybrids as potential anti-HIV-1 NNRT inhibitors.
    Kasralikar HM; Jadhavar SC; Goswami SV; Kaminwar NS; Bhusare SR
    Bioorg Chem; 2019 May; 86():437-444. PubMed ID: 30771690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biological evaluation and molecular modeling of 2-Hydroxyisoquinoline-1,3-dione analogues as inhibitors of HIV reverse transcriptase associated ribonuclease H and polymerase.
    Tang J; Vernekar SKV; Chen YL; Miller L; Huber AD; Myshakina N; Sarafianos SG; Parniak MA; Wang Z
    Eur J Med Chem; 2017 Jun; 133():85-96. PubMed ID: 28384548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action.
    Esposito F; Mandrone M; Del Vecchio C; Carli I; Distinto S; Corona A; Lianza M; Piano D; Tacchini M; Maccioni E; Cottiglia F; Saccon E; Poli F; Parolin C; Tramontano E
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28637198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uvaria angolensis as a promising source of inhibitors of HIV-1 RT-associated RNA-dependent DNA polymerase and RNase H functions.
    Ngoutane Mfopa A; Corona A; Eloh K; Tramontano E; Frau A; Boyom FF; Caboni P; Tocco G
    Nat Prod Res; 2018 Mar; 32(6):640-647. PubMed ID: 28540745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted -2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors.
    Gawali R; Trivedi J; Bhansali S; Bhosale R; Sarkar D; Mitra D
    Eur J Med Chem; 2018 Sep; 157():310-319. PubMed ID: 30099253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors.
    Rawal RK; Prabhakar YS; Katti SB; De Clercq E
    Bioorg Med Chem; 2005 Dec; 13(24):6771-6. PubMed ID: 16198576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents.
    Barreca ML; Balzarini J; Chimirri A; De Clercq E; De Luca L; Höltje HD; Höltje M; Monforte AM; Monforte P; Pannecouque C; Rao A; Zappalà M
    J Med Chem; 2002 Nov; 45(24):5410-3. PubMed ID: 12431069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural modulation study of inhibitory compounds for ribonuclease H activity of human immunodeficiency virus type 1 reverse transcriptase.
    Yanagita H; Fudo S; Urano E; Ichikawa R; Ogata M; Yokota M; Murakami T; Wu H; Chiba J; Komano J; Hoshino T
    Chem Pharm Bull (Tokyo); 2012; 60(6):764-71. PubMed ID: 22689429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of naphthalenesulfonic acid small molecules as selective inhibitors of the DNA polymerase and ribonuclease H activities of HIV-1 reverse transcriptase.
    Mohan P; Loya S; Avidan O; Verma S; Dhindsa GS; Wong MF; Huang PP; Yashiro M; Baba M; Hizi A
    J Med Chem; 1994 Aug; 37(16):2513-9. PubMed ID: 7520080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2,4,5-Trisubstituted thiazole derivatives as HIV-1 NNRTIs effective on both wild-type and mutant HIV-1 reverse transcriptase: Optimization of the substitution of positions 4 and 5.
    Xu Z; Guo J; Yang Y; Zhang M; Ba M; Li Z; Cao Y; He R; Yu M; Zhou H; Li X; Huang X; Guo Y; Guo C
    Eur J Med Chem; 2016 Nov; 123():309-316. PubMed ID: 27484516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribonuclease H/DNA Polymerase HIV-1 Reverse Transcriptase Dual Inhibitor: Mechanistic Studies on the Allosteric Mode of Action of Isatin-Based Compound RMNC6.
    Corona A; Meleddu R; Esposito F; Distinto S; Bianco G; Masaoka T; Maccioni E; Menéndez-Arias L; Alcaro S; Le Grice SF; Tramontano E
    PLoS One; 2016; 11(1):e0147225. PubMed ID: 26800261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 2-Hydroxyisoquinoline-1,3-Dione Active-Site RNase H Inhibitor Binds in Multiple Modes to HIV-1 Reverse Transcriptase.
    Kirby KA; Myshakina NA; Christen MT; Chen YL; Schmidt HA; Huber AD; Xi Z; Kim S; Rao RK; Kramer ST; Yang Q; Singh K; Parniak MA; Wang Z; Ishima R; Sarafianos SG
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
    Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
    Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of Thiazolo[3, 2-a]Pyrimidine derivatives as novel RNase H inhibitors.
    Zhao KX; Zhang YY; Wang JS; Wang S; Corona A; Maloccu S; Tramontano E; Pannecouque C; De Clercq E; Meng G; Wang L; Chen FE
    Bioorg Chem; 2024 Jul; 148():107495. PubMed ID: 38805850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo parallel design, synthesis and evaluation of inhibitors against the reverse transcriptase of human immunodeficiency virus type-1 and drug-resistant variants.
    Herschhorn A; Lerman L; Weitman M; Gleenberg IO; Nudelman A; Hizi A
    J Med Chem; 2007 May; 50(10):2370-84. PubMed ID: 17458947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, HIV-1 RT inhibitory, antibacterial, antifungal and binding mode studies of some novel N-substituted 5-benzylidine-2,4-thiazolidinediones.
    Bahare RS; Ganguly S; Choowongkomon K; Seetaha S
    Daru; 2015 Jan; 23(1):6. PubMed ID: 25617150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.